Lantheus Medical Imaging

A Phase 4 Open-Label Multicenter Study of PYLARIFY® PET/CT or PET/MRI in Men With Newly Diagnosed Favorable Intermediate Risk (FIR) Prostate Cancer

Description:

The purpose of this study is to learn whether PYLARIFY PET imaging (study scan) can safely and accurately detect the presence or absence of prostate cancer growing beyond the prostate gland in men with favorable intermediate risk prostate cancer.

Contacts:

Senior Clinical Trial Manager

pyl4301studyinfo@lantheus.com

1(646) 975-2540

Patient Education


Patient Education Not Yet Provided

Publications


Publications Not Yet Provided

Locations